Menu
Back to Journals » Cancer Management and Research » Volume 14
Original Research
Real-World Outcomes and Prognostic Factors Among Patients with Advanced Non-Small Cell Lung Cancer and High PD-L1 Expression Treated with Immune Checkpoint Inhibitors as First-Line Therapy
| Total article views | HTML views | PDF downloads | Totals | ||
|---|---|---|---|---|---|
| 4,024 | Dovepress* | 3,730+ | 87 | 3,817 | |
| PubMed Central* | 294 | 125 | 419 | ||
| Totals | 4,024 | 212 | 4,236 | ||
| *Since 16 November 2022 | |||||
View citations on PubMed Central and Google Scholar